We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Ruxolitinib

Australian Public Assessment Report

AusPAR

AusPAR: Ruxolitinib [PDF, 1.14 MB]

AusPAR: Ruxolitinib [Word, 1.76 MB]

Attachment: Product Information: Ruxolitinib [PDF, 307.07 KB]

Attachment: Product Information: Ruxolitinib [Word, 138.36 KB]

Attachment: Extract from Clinical Evaluation Report: Ruxolitinib [PDF, 2.09 MB]

Attachment: Extract from Clinical Evaluation Report: Ruxolitinib [Word, 4.6 MB]

Device/Product Name

Jakavi

Active ingredients

Ruxolitinib

AusPAR Date

21 January 2014

Published

27 February 2014

Submission Number

PM-2012-01504-3-4

Submission Type

New chemical entity

Decision

Approved